Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr 28;1-9.
doi: 10.1007/s15010-020-01432-5. Online ahead of print.

Clinical Characteristics of 145 Patients With Corona Virus Disease 2019 (COVID-19) in Taizhou, Zhejiang, China

Affiliations
Free PMC article

Clinical Characteristics of 145 Patients With Corona Virus Disease 2019 (COVID-19) in Taizhou, Zhejiang, China

Qingqing Chen et al. Infection. .
Free PMC article

Abstract

Objective: The aim of this study was to investigate the clinical characteristics of Corona Virus Disease 2019 in Taizhou, China.

Methods: A single center retrospective observational study was performed between Jan 1, 2020 and Mar 11, 2020 at Taizhou Public Health Medical Center, Zhejiang, China. All patients with confirmed Corona Virus Disease 2019 were enrolled, and their clinical data were gathered by reviewing electronic medical records. Outcomes of severely ill patients and non-severely ill patients were compared.

Results: Of 145 hospitalized patients with COVID-19, the average age was 47.5 years old (standard deviation, 14.6) and 54.5% were men. Hypertension was the most common comorbidity (15.2%), followed by diabetes mellitus (9.7%). Common symptoms included dry cough (81.4%), fever (75.2%), anorexia (42.8%), fatigue (40.7%), chest tightness (32.4%), diarrhea (26.9%) and dizziness (20%). According to imaging examination, 79.3% patients showed bilateral pneumonia, 18.6% showed unilateral pneumonia, 61.4% showed ground-glass opacity, and 2.1% showed no abnormal result. Compared with non-severely ill patients, severely ill patients were older (mean, years, 52.8 vs. 45.3, p < 0.01), had a higher proportion of diabetes mellitus (16.3% vs. 6.9%, p = 0.08), had a higher body mass index (mean, 24.78 vs. 23.20, p = 0.02) and were more likely to have fever (90.7% vs. 68.6%, p = 0.01), anorexia (60.5% vs. 35.3%, p = 0.01), chest tightness (60.5% vs.20.6%, p < 0.01) and dyspnea (7.0% vs. 0%, p = 0.03). Of the 43 severely ill patients, 6 (14%) received high-flow nasal cannula oxygen therapy, and 1 (2.3%) received invasive mechanical ventilation.

Conclusions: Older patients or patients with comorbidities such as obesity or diabetes mellitus were more likely to have severe condition. Treatments of COVID-19 is still experimental and more clinical trials are needed.

Keywords: COVID-19; Clinical characteristics; Corona virus disease 2019; Epidemiology; Outcomes; SARS-CoV-2; Treatment.

Conflict of interest statement

The authors declare that they have no conflict interests.

Figures

Fig. 1
Fig. 1
Multiple patchy shadows and ground-glass opacity were observed in both lungs
Fig. 2
Fig. 2
Ground-glass opacity and patchy and patchy high-density shadows were mainly on the left middle lobe and the lower left lobe, edges were blurred, ground-glass opacity were observed in the upper left lobe. A few fibrous high-density shadows were observed in the left lower lobe

Similar articles

See all similar articles

References

    1. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J Med Virol. 2020;92:401–402. doi: 10.1002/jmv.25678. - DOI - PMC - PubMed
    1. Hui DS, Ia E, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-The latest novel coronavirus outbreak in Wuhan China. Int J Infect Dis. 2020;91:264–266. doi: 10.1016/j.ijid.2020.01.009. - DOI - PMC - PubMed
    1. Report of novel coronavirus-infected pneumonia in China. Wuhan Municipal Health Commission. 2020. https://wjw.wuhan.gov.cn/front/web/showDetail/2020012009077. Accessed March 28th 2020
    1. Paules CI, Marston HD, Fauci AS. Coronavirus infections-more than just the common cold. JAMA. 2020 doi: 10.1001/jama.2020.0757. - DOI - PubMed
    1. Report of clustering pneumonia of unknown etiology in Wuhan City. Wuhan Municipal Health Commission. 2019. https://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989. Accessed March 28th 2020.

LinkOut - more resources

Feedback